Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s briefing runs through the places where cannabis policy is actually being decided right now: Virginia lawmakers closing in on a sales framework, Texas candidates turning THC into a campaign issue, and Washington navigating the optics of money and rescheduling. Beneath it all is the same question regulators and investors both face: who is writing the rules, and whether those rules will hold once markets move.
Today’s edition is supported by Forward Future AI and Mindstream. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.
🏛️ Virginia’s market build
🗳️ Texas campaigns on THC
💰 Money follows reform
The issue of power is always the issue of who decides.
Know What Matters in Tech Before It Hits the Mainstream
By the time AI news hits CNBC, CNN, Fox, and even social media, the info is already too late. What feels “new” to most people has usually been in motion for weeks — sometimes months — quietly shaping products, markets, and decisions behind the scenes.
Forward Future is a daily briefing for people who want to stay competitive in the fastest evolving technology shift we’ve ever seen. Each day, we surface the AI developments that actually matter, explain why they’re important, and connect them to what comes next.
We track the real inflection points: model releases, infrastructure shifts, policy moves, and early adoption signals that determine how AI shows up in the world — long before it becomes a talking point on TV or a trend on your feed.
It takes about five minutes to read.
The insight lasts all day.

Fast-moving headlines, flagged for what matters.
Virginia lawmakers advanced companion bills HB 642 and SB 542 to finally build a regulated adult-use sales market, moving the package closer to Gov. Abigail Spanberger. The bills still diverge on timing and taxes, and that matters because revenue design decides staffing, enforcement tempo, and whether the regulator can keep pace with license growth. The long game here sits with oversight and the existing medical licensees, since conversion rules and market share will shape who dominates the first two years. This has been a long time coming, and a rushed launch would hand critics the one thing they always want: visible disorder. The next decision point is conference, where the start date, tax stack, and regulatory mechanics decide whether Virginia opens with confidence or improvisation. (Marijuana Moment)
A cannabis-funded committee, American Rights and Reform PAC, gave $2.05 million to President Donald Trump’s super PAC MAGA Inc. ahead of his rescheduling directive, according to FEC-linked reporting. The PAC’s ties to Legalize America and a Curaleaf executive as treasurer put a corporate thumbprint on a political strategy built around access and optics. That may be how Washington works, and it also hands opponents a clean narrative: reform as pay-to-play instead of public health or public safety. The administrative process will still grind, but the credibility tax starts immediately, especially if the timeline slips or enforcement choices look selective. The industry’s next federal fight will require allies who can defend the merits without defending the method. (Sechat)
New York’s seed-to-sale requirements hit a hard deadline Saturday, March 7th, and retailers have already been returning products to processors for relabeling. Small processors are describing six-figure equipment buys and workflow redesigns just to keep inventory moving, which turns compliance into a cash-flow event. Metrc is walking into an inherited mess and trying to bring order to a market that has been running on patchwork, so some pain was always baked in. The risk is execution, because a clumsy rollout punishes the compliant first and hands the illicit market another season of advantage. The payoff is legitimacy, and the state has to earn it with a transition that feels fair and workable in the real world. (Ganjapreneur)
The Los Angeles City Council voted 13–0 to explore a tax amnesty program for licensed cannabis businesses, targeting more than 500 delinquent operators that reportedly owe about $400 million. The proposal would waive penalties and interest and allow installment plans, with collections routed across general operations, illegal-shop enforcement, and social equity grant funding. City officials are also acknowledging a statute-of-limitations squeeze, which turns this into a salvage operation as much as a compliance reset. The immediate question is replication: if this produces real collections, other jurisdictions that cannot fund equity commitments may view amnesty as a faster bridge than new taxes. The governance risk stays real too, because any amnesty has to separate distressed businesses from business models built on nonpayment. (MyNewsLA)
Wisconsin Gov. Tony Evers urged the state’s congressional delegation to modify new federal hemp rules scheduled to take effect in November 2026. Evers does not typically posture around D.C., and this letter reads like a governor who sees a regional economic hit coming and wants the delegation on record early. The administration is framing the stakes as jobs, farm income, and supply-chain investment as 2026 planting decisions approach. If the Wisconsin delegation engages, it adds weight, because federal lawmakers hear home-state economic risk differently than they hear industry lobbying. The near-term consequence is political triage: either Congress adjusts the standard or Wisconsin’s market reorganizes in a way the state did not choose. (WisPolitics)
Candidates across state and federal races met at Leaf and Legends in Austin to talk THC policy as Texans vote in March primaries. The policy backdrop is Senate Bill 3, the hemp-THC ban that passed the Legislature and was vetoed by Gov. Greg Abbott, leaving uncertainty that is now a campaign issue. At the forum, Democratic Texas House candidate Gigs Hodges said she wants hemp industry voices guiding her votes, while Democratic congressional candidate Justin Early tied rescheduling to SBA-style support for small businesses. Two candidates running in TX-10, Democrat Dawn Marshall and Republican Brandon Hawbaker, both warned against Texas DSHS licensing-fee proposals that could jump into the tens of thousands, which would reshape the market by administrative pricing. The consequence is a real political opening: when both parties start talking about fees, science, and veterans instead of moral panic, the state edges closer to regulation that can survive contact with reality. (Spectrum News 1)
A University of New Hampshire survey finds 63% of Massachusetts residents oppose the 2026 ballot initiative to roll back adult-use legalization, with 48% strongly opposed. The petition’s structure would keep medical cannabis and still allow limited possession and gifting, while ending legal retail sales and home cultivation, which is a high-friction rollback for voters who already treat the market as normal. The Legislature faces a May 5th decision point, with another signature round by July 1st if lawmakers decline to enact it. We have been writing about the industry’s need to move together on existential threats, and this is the moment for it, because both hemp and marijuana become easy campaign fodder when they free-lance their politics. The immediate consequence is strategic: repeal advocates need persuasion, and the industry needs discipline. (Marijuana Moment)
Connecticut lawmakers are weighing a bill that would allow THC-infused beverages in bars and restaurants, with a public hearing scheduled for Wednesday. The Wine and Spirit Wholesalers of Connecticut want the category pulled into an alcohol-style three-tier structure, which quietly shifts power toward incumbent distribution lanes. House Majority Leader Jason Rojas is pointing to soft alcohol sales, which signals economic motivation alongside consumer demand. Rep. David Rutigliano is pressing the liability question, because intoxication management is harder with THC and insurers price ambiguity aggressively. The practical outcome will be written in service rules, training standards, and who bears the liability when a night goes sideways. (Stamford Advocate)
New Orleans Rep. Candace Newell filed legislation that would allow adult-use sales in Louisiana through the state’s nine medical marijuana dispensary licensees, with sales required at a separate location. The structure reads like a controlled pilot that leans on existing compliance infrastructure while the state tests demand, enforcement capacity, and tax design. Newell is also framing legalization as budget management, arguing marijuana tax revenue could help backfill expected cuts in federal funding. The bill is set for debate when the regular session begins Monday, March 9th, and Newell is already signaling the votes will be hard to find. The real decision point is whether lawmakers treat this as a revenue tool with guardrails or a values fight with no off-ramp. The consequence is coalition math: the fiscal frame can bring in strange allies, and it can also harden opposition if it feels like a tax grab without a public-safety plan. (Louisiana Radio Network)
An op-ed argues rescheduling will not stabilize cannabis without insurance reimbursement reform, and the instinct is understandable. Insurance coverage is tied to treatments, prescription access, and clinical evidence, which means trials, formulations, and regulatory pathways that move on medical timelines, not political ones. Even with rescheduling, payers and pharmacy benefit managers will still ask what is approved, what is indicated, and how fraud and utilization are controlled. There is also a hard strategic risk: large pharma can buy IP, control access, and shelve competing products in favor of pipelines already funded by R&D budgets. The consequence is patience with purpose, because rescheduling can open doors, while reimbursement requires years of disciplined evidence-building and smart protection of medical innovation. (Marijuana Moment)
RYTHM Inc, formerly Agrify, tells investors it has pivoted toward hemp-derived THC beverages and licensed cannabis brands after exiting cultivation and extraction. The filing describes reliance on shared services tied to Green Thumb affiliates alongside significant secured convertible debt and limited cash, which makes execution risk feel immediate. It also flags regulatory exposure, warning that federal appropriations changes could bar its current hemp-derived THC products after a grace period. That is not an abstract risk, because the business model sits on product legality, and legality sits on a political clock. The investor consequence is simple: when Washington tightens definitions, capital markets react faster than consumers do. (Stock Titan)
A marijuana dispensary suing the City of Menominee says a competitor is improperly helping cover the city’s legal bills and it wants Mayor Casey Hoffman to investigate. Puff Cannabis Company says the arrangement creates bias risk while the city continues to withhold an occupancy permit after approving Puff’s license in December 2024. City attorney Matthew Cross says the payments stem from a 2023 settlement agreement tied to prior litigation, with multiple companies sharing obligations. Puff is seeking a court order to open and at least $20 million in damages, and the city says it will pursue dismissal. The governance consequence is credibility decay, because once financing and permitting get braided together, every future licensing decision carries suspicion whether it deserves it or not. (MLive)
The Coffee Joint, the first licensed cannabis lounge in the country when it opened in 2018, closed on February 25th and its owners plan to surrender the cannabis consumption license to pursue a psilocybin healing center permit. Co-owner Rita Tsalyuk says Colorado law bars a single address from holding both a cannabis business license and a psilocybin license, which forces a clean swap. The new concept, AlmaDose, is positioned around low-dose adult experiences, which reads like an attempt to build steadier demand and lower volatility. The Coffee Joint also faced early restrictions and later ventilation and compliance costs that limited the upside of being first. The market consequence is that licensing design is steering entrepreneurs toward the regime that offers the clearer path to sustainable revenue. (Westword)
The Woodland Trust says more than four tonnes of cannabis farm waste has been dumped over the past year at Brede High Woods in East Sussex, and cleanup has already cost thousands. The charity warns the dumping threatens streams, ponds, and fragile habitats that support rare species, and staff describe the problem as relentless. This is the ecological version of cost shifting, where illicit activity pushes disposal and enforcement burdens onto land managers and local communities. The trust is responding with blocked access routes and cameras, which signals how persistent the problem has become. The consequence is blunt: environmental harm becomes part of the illicit market’s footprint, even when the cultivation is out of sight. (BBC News)
Turn AI Into Extra Income
You don’t need to be a coder to make AI work for you. Subscribe to Mindstream and get 200+ proven ideas showing how real people are using ChatGPT, Midjourney, and other tools to earn on the side.
From small wins to full-on ventures, this guide helps you turn AI skills into real results, without the overwhelm.
🌱 Wellness season is here, and cannabis media is already packaging THC as a lifestyle assist for spring fitness goals. This framing keeps demand sticky, and it also drifts toward implied health claims that state regulators and advertisers watch closely when the copy gets too confident. (The Fresh Toast)
🏃 Chicago’s running scene is getting its own cannabis flavored mythology, with weed pitched as part of the ritual for endurance, recovery, and community. The culture is real, and the policy drag is real too, because public consumption rules and workplace testing regimes still sit right on top of this lifestyle narrative. (High Times)
🏆 Leafly ranked Garden Wonders Cannabis in Millville, MA as the fifth best dispensary in the U.S., crediting customer satisfaction and a close relationship with regulars. For Massachusetts retail, national list placement is not fluff, it drives border traffic and reinforces that service quality still moves share in a crowded market. (USA TODAY Network New England)
🌿 State hemp rules are diverging fast, and the U.S. Hemp Roundtable’s update reads like a map of where markets will survive and where they will get legislated into the shadows. Definitions, caps, and taxes are now doing the work of prohibition in some states, while others are building regulated beverage lanes that keep commerce in daylight. (HempSupporter; U.S. Hemp Roundtable)




